Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Product & Service Announcements

How can Direct-to-Patient Services Reduce the Burden on Traditional Healthcare?

Ageing populations and an increasing number of people living with long term chronic conditions are prompting healthcare systems worldwide to look again at how – and where – they provide care. 

Read the rest of entry »

HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples

(Los Angeles, CA and Glasgow U.K. – March 28, 2019) HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.

Read the rest of entry »

Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™Lung Liquid Biopsy Test

Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding in the Management of Patients with Advanced Non-Small-Cell Lung Cancer . Inivata, a leader in liquid biopsy,  announced on 13 September that Palmetto GBA, a Medicare Administrative Contractor that  evaluates diagnostic technology through its laboratory technology assessment group, MolDx, has published a draft local coverage determination (LCD) for the InVisionFirst-Lung test.

Read the rest of entry »

Diamond Pharma Services provided EU regulatory support to Kite Pharma Inc.

'A Diamond does not start out polished and shining, but with enough pressure, hard work and time it becomes brilliant'
Kite Pharma secures breakthrough European positive opinion for CAR-T cell cancer therapy.

Read the rest of entry »

Heart disease stem cell therapy can shrink deadly scar tissue

UK trial for breakthrough cardiac treatment that can 'fix' the damage caused by heart attacks

Read the rest of entry »

Oxford MEStar announce the lauch of measure Bowel Health - a DIY digital home test to detect signs of bowel cancer

measure Bowel Health is an affordable DIY Bowel Health Test that combines ease of use with cutting edge technology. measure is fast, hygienic and discreet and it works by detecting low-level bleeding invisible to the human eye that may be an early sign of gastrointestinal disease, including cancer and stomach ulcers

Read the rest of entry »

Cello Health announces launch of new business Cello Health Logic

Cello Health has today announced the launch of their new social media insight and analytics business, Cello Health Logic. The business, born out of Cello Health Insight’s dedicated digital division, aims to meet the need for pharmaceutical and healthcare clients to tap into and better understand the huge volume of real-world conversational data that has the potential to drive strategic decision making.

Read the rest of entry »

Wickham Laboratories Article on Endotoxin Detection Methods Published by Pharmaceutical Technology Europe

Wickham Laboratories is pleased to announce the publication of a technical editorial “Comparing Endotoxin Detection Methods” which is featured in Pharmaceutical Technology Europe’s November 2017 issue.

Read the rest of entry »

Examination of Non-sterile Products: Application Note Published in European Pharmaceutical Review

Wickham Laboratories is pleased to announce their most recent Application Note, “Examination of Non-sterile Products: Tests for Specified Microorganisms” which is featured in the December 2017 issue of European Pharmaceutical Review.

Read the rest of entry »

Arecor Announces Successful Vaccine Stabilising Formulation Technology to More Effectively Combat Two Major Diseases of Livestock in the Developing World

Arecor and its partner, non-profit company, Global Alliance for Livestock Veterinary Medicines (GALVmed), have successfully stabilised liquid formulations of vaccines to combat two major diseases of livestock across the developing world including Africa, Asia and the Middle East In this work, the ArestatTM technology has been applied to enable a vaccine to be distributed pre-prepared in a liquid format without the requirement for in-field reconstitution from the freeze-dried powder form ArestatTM technology has also been applied to reduce the cost of a batch of vaccine diluent by 96 per cent., thereby improving its distribution and uptake by farmers Arecor’s formulation technology work has been supported by Innovate UK through UK aid of the UK government and the Bill & Melinda Gates Foundation Cambridge, UK., 8th December 2017: Arecor Ltd (“the Company”),  a leader in developing superior biopharmaceuticals through the application of an innovative formulation technology ...

Read the rest of entry »

Pages: Previous1234567NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.